FPAQX
Price
$8.50
Change
-$0.04 (-0.47%)
Updated
May 21 closing price
Net Assets
676.47M
FPFZX
Price
$8.51
Change
-$0.03 (-0.35%)
Updated
May 21 closing price
Net Assets
676.47M
Interact to see
Advertisement

FPAQX vs FPFZX

Header iconFPAQX vs FPFZX Comparison
Open Charts FPAQX vs FPFZXBanner chart's image
Franklin PA Tax-Free Income A
Price$8.50
Change-$0.04 (-0.47%)
VolumeN/A
Net Assets676.47M
Franklin PA Tax-Free Income Adv
Price$8.51
Change-$0.03 (-0.35%)
VolumeN/A
Net Assets676.47M
FPAQX vs FPFZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FPAQX vs. FPFZX commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FPAQX is a Hold and FPFZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FPAQX (676M) and FPFZX (676M) have equal amount of cash in the bank . FPFZX pays higher dividends than FPAQX: FPFZX (3.44) vs FPAQX (3.19). FPAQX was incepted earlier than FPFZX: FPAQX (7 years) vs FPFZX (16 years). FPAQX (0.84) is less costly to investors than FPFZX (0.59). FPAQX (18.22) and FPFZX (18.22) have comparable annual turnover. FPAQX has a lower initial minimum investment than FPFZX: FPAQX (1000) vs FPFZX (100000). FPFZX annual gain was more profitable for investors over the last year : 0.47 vs. FPAQX (0.34). FPFZX return over 5 years is better than : -4.28 vs. FPAQX (-4.97).
FPAQXFPFZXFPAQX / FPFZX
Total Expense Ratio0.840.59142%
Annual Report Gross Expense Ratio0.840.59142%
Fund Existence7 years16 years-
Gain YTD-2.152-2.18499%
Front Load4%N/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets676M676M100%
Annual Yield % from dividends3.193.4493%
Returns for 1 year0.340.4772%
Returns for 3 years4.585.0790%
Returns for 5 years-4.97-4.28116%
Returns for 10 yearsN/A-5.52-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNBAX19.75N/A
N/A
Manning & Napier Pro-Blend Extnd Term S
SDVRX24.74N/A
N/A
PGIM Quant Solutions Mid-Cap Val R
MVISX41.00N/A
N/A
Patient Opportunity IS
BGRIX92.19N/A
N/A
Baron Growth Instl
SUSLX14.70N/A
N/A
Lazard US Sustainable Equity Open